TheraKine Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- TheraKine Ltd.'s estimated annual revenue is currently $310k per year.
- TheraKine Ltd.'s estimated revenue per employee is $155,000
Employee Data
- TheraKine Ltd. has 2 Employees.
- TheraKine Ltd. grew their employee count by 0% last year.
TheraKine Ltd.'s People
Name | Title | Email/Phone |
---|
TheraKine Ltd. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is TheraKine Ltd.?
TheraKine is an ophthalmic specialty pharmaceutical company bringing the power of biologics and biological mechanisms to diseases of the eye. TheraKine is developing therapeutic systems to improve vision and prevent blindness. We recognize that inflammation is the common cause of vision loss in all serious eye diseases. Our pipeline of therapies attack inflammation by using clinically proven biologic drugs and small molecule inhibitors and packaging them in Sustained Release Delivery Systems. These delivery systems will enable the drugs to be placed inside the Blood-Eye Barrier at the source of inflammation, and will last for several months, resulting in better outcomes, less side-effects and lower cost.
keywords:N/AN/A
Total Funding
2
Number of Employees
$310k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.2M | 2 | -33% | N/A |
#2 | $0.2M | 2 | -98% | N/A |
#3 | $0M | 2 | -33% | $26M |
#4 | $0.1M | 2 | -80% | N/A |
#5 | $0.2M | 2 | -33% | N/A |